SEER INC

Seer Inc.’s July 8 insider sale by Nishar Dipchand is a routine, rule‑compliant trade with minimal price impact, underscoring steady leadership confidence amid high‑volatility biotech market dynamics.

Seer Inc. insider sales reveal CFO’s liquidity plan, not a confidence dip—maintaining long‑term stake while meeting RSU cash needs.